Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali

Clinical trial NCT00460525 · COMPLETED

Trial details

NCT number: NCT00460525
Sponsor: U.S. Army Medical Research and Development Command
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plasmodium Falciparum Malaria

Start date: 2007-05-01
Primary completion: 2009-07-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.